| Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window D Vanhoutte, M Schellings, Y Pinto, S Heymans Cardiovascular research 69 (3), 604-613, 2006 | 375 | 2006 |
| Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction MWM Schellings, D Vanhoutte, M Swinnen, JP Cleutjens, J Debets, ... Journal of Experimental Medicine 206 (1), 113-123, 2009 | 233 | 2009 |
| A thrombospondin-dependent pathway for a protective ER stress response JM Lynch, M Maillet, D Vanhoutte, A Schloemer, MA Sargent, NS Blair, ... Cell 149 (6), 1257-1268, 2012 | 220 | 2012 |
| Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6 S Loges, T Schmidt, M Tjwa, K Van Geyte, D Lievens, E Lutgens, ... Blood, The Journal of the American Society of Hematology 115 (11), 2264-2273, 2010 | 191 | 2010 |
| Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition CE Murdoch, S Chaubey, L Zeng, B Yu, A Ivetic, SJ Walker, D Vanhoutte, ... Journal of the American College of Cardiology 63 (24), 2734-2741, 2014 | 183 | 2014 |
| TIMPs and cardiac remodeling:‘Embracing the MMP-independent-side of the family’ D Vanhoutte, S Heymans Journal of molecular and cellular cardiology 48 (3), 445-453, 2010 | 174 | 2010 |
| Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction D Vanhoutte, MWM Schellings, M Götte, M Swinnen, V Herias, MK Wild, ... Circulation 115 (4), 475-482, 2007 | 166 | 2007 |
| Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis S Heymans, M Pauschinger, A De Palma, A Kallwellis-Opara, S Rutschow, ... Circulation 114 (6), 565-573, 2006 | 152 | 2006 |
| RhoA protects the mouse heart against ischemia/reperfusion injury SY Xiang, D Vanhoutte, DP Del Re, NH Purcell, H Ling, I Banerjee, ... The Journal of clinical investigation 121 (8), 3269-3276, 2011 | 106 | 2011 |
| Absence of thrombospondin-2 causes age-related dilated cardiomyopathy M Swinnen, D Vanhoutte, GC Van Almen, N Hamdani, MWM Schellings, ... Circulation 120 (16), 1585-1597, 2009 | 106 | 2009 |
| Syndecan-1 amplifies angiotensin II–induced cardiac fibrosis MWM Schellings, D Vanhoutte, GC van Almen, M Swinnen, JJG Leenders, ... Hypertension 55 (2), 249-256, 2010 | 100 | 2010 |
| Cardiomyocyte-specific transforming growth factor β suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after … PP Rainer, S Hao, D Vanhoutte, DI Lee, N Koitabashi, JD Molkentin, ... Circulation research 114 (8), 1246-1257, 2014 | 99 | 2014 |
| Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening LNL Van Aelst, S Voss, P Carai, R Van Leeuwen, D Vanhoutte, ... Circulation research 116 (3), 425-436, 2015 | 91 | 2015 |
| Acute catecholamine exposure causes reversible myocyte injury without cardiac regeneration M Wallner, JM Duran, S Mohsin, CD Troupes, D Vanhoutte, G Borghetti, ... Circulation research 119 (7), 865-879, 2016 | 87 | 2016 |
| Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy D Vanhoutte, TG Schips, A Vo, KM Grimes, TA Baldwin, MJ Brody, ... Nature communications 12 (1), 3928, 2021 | 74 | 2021 |
| Deletion of periostin protects against atherosclerosis in mice by altering inflammation and extracellular matrix remodeling JA Schwanekamp, A Lorts, RJ Vagnozzi, D Vanhoutte, JD Molkentin Arteriosclerosis, thrombosis, and vascular biology 36 (1), 60-68, 2016 | 71 | 2016 |
| Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells AP Papageorgiou, M Swinnen, D Vanhoutte, T VandenDriessche, ... Cardiovascular research 94 (1), 115-124, 2012 | 71 | 2012 |
| Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator M Rother, S Krohn, G Kania, D Vanhoutte, A Eisenreich, X Wang, ... Circulation 122 (25), 2688-2698, 2010 | 62 | 2010 |
| Thrombospondin expression in myofibers stabilizes muscle membranes D Vanhoutte, TG Schips, JQ Kwong, J Davis, A Tjondrokoesoemo, ... Elife 5, e17589, 2016 | 50 | 2016 |
| Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability TG Schips, D Vanhoutte, A Vo, RN Correll, MJ Brody, H Khalil, J Karch, ... Nature communications 10 (1), 76, 2019 | 43 | 2019 |
Heymans SVerified email at maastrichtuniversity.nl
